Elewski, Boni, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan Mendelsohn, Jeffrey Parno, and Kenneth Gordon. “Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S22. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/305.